MDWD
Price
$20.33
Change
-$0.53 (-2.54%)
Updated
Jul 25 closing price
Capitalization
219.72M
16 days until earnings call
SCPH
Price
$5.60
Change
-$0.24 (-4.11%)
Updated
Jul 25 closing price
Capitalization
295.64M
10 days until earnings call
Interact to see
Advertisement

MDWD vs SCPH

Header iconMDWD vs SCPH Comparison
Open Charts MDWD vs SCPHBanner chart's image
MediWound
Price$20.33
Change-$0.53 (-2.54%)
Volume$38.03K
Capitalization219.72M
scPharmaceuticals
Price$5.60
Change-$0.24 (-4.11%)
Volume$497.06K
Capitalization295.64M
MDWD vs SCPH Comparison Chart in %
Loading...
MDWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MDWD vs. SCPH commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDWD is a Hold and SCPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (MDWD: $20.33 vs. SCPH: $5.60)
Brand notoriety: MDWD and SCPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDWD: 66% vs. SCPH: 160%
Market capitalization -- MDWD: $219.72M vs. SCPH: $295.64M
MDWD [@Biotechnology] is valued at $219.72M. SCPH’s [@Biotechnology] market capitalization is $295.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDWD’s FA Score shows that 1 FA rating(s) are green whileSCPH’s FA Score has 0 green FA rating(s).

  • MDWD’s FA Score: 1 green, 4 red.
  • SCPH’s FA Score: 0 green, 5 red.
According to our system of comparison, MDWD is a better buy in the long-term than SCPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDWD’s TA Score shows that 4 TA indicator(s) are bullish while SCPH’s TA Score has 5 bullish TA indicator(s).

  • MDWD’s TA Score: 4 bullish, 6 bearish.
  • SCPH’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SCPH is a better buy in the short-term than MDWD.

Price Growth

MDWD (@Biotechnology) experienced а -0.64% price change this week, while SCPH (@Biotechnology) price change was +13.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

MDWD is expected to report earnings on Aug 12, 2025.

SCPH is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SCPH($296M) has a higher market cap than MDWD($220M). SCPH YTD gains are higher at: 58.192 vs. MDWD (14.213). MDWD has higher annual earnings (EBITDA): -29.43M vs. SCPH (-83.9M). SCPH has more cash in the bank: 57.5M vs. MDWD (38.3M). MDWD has less debt than SCPH: MDWD (6.42M) vs SCPH (52.4M). SCPH has higher revenues than MDWD: SCPH (42M) vs MDWD (19.2M).
MDWDSCPHMDWD / SCPH
Capitalization220M296M74%
EBITDA-29.43M-83.9M35%
Gain YTD14.21358.19224%
P/E RatioN/AN/A-
Revenue19.2M42M46%
Total Cash38.3M57.5M67%
Total Debt6.42M52.4M12%
FUNDAMENTALS RATINGS
MDWD vs SCPH: Fundamental Ratings
MDWD
SCPH
OUTLOOK RATING
1..100
722
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
94100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
5236
P/E GROWTH RATING
1..100
3100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SCPH's Valuation (64) in the Pharmaceuticals Major industry is in the same range as MDWD (66) in the Pharmaceuticals Other industry. This means that SCPH’s stock grew similarly to MDWD’s over the last 12 months.

MDWD's Profit vs Risk Rating (94) in the Pharmaceuticals Other industry is in the same range as SCPH (100) in the Pharmaceuticals Major industry. This means that MDWD’s stock grew similarly to SCPH’s over the last 12 months.

MDWD's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as SCPH (100) in the Pharmaceuticals Major industry. This means that MDWD’s stock grew similarly to SCPH’s over the last 12 months.

SCPH's Price Growth Rating (36) in the Pharmaceuticals Major industry is in the same range as MDWD (52) in the Pharmaceuticals Other industry. This means that SCPH’s stock grew similarly to MDWD’s over the last 12 months.

MDWD's P/E Growth Rating (3) in the Pharmaceuticals Other industry is significantly better than the same rating for SCPH (100) in the Pharmaceuticals Major industry. This means that MDWD’s stock grew significantly faster than SCPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MDWDSCPH
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 6 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 21 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
MDWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YAHOY7.700.09
+1.12%
LY Corporation
HSEEF0.13N/A
N/A
Hill Incorporated
NWHUF3.59N/A
N/A
Northwest Healthcare Properties Real Estate Investment
UVRBF1.61N/A
N/A
Universal Robina
IUGND0.19-0.02
-8.57%
Imugene Ltd

MDWD and

Correlation & Price change

A.I.dvisor tells us that MDWD and VRNA have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MDWD and VRNA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDWD
1D Price
Change %
MDWD100%
-2.54%
VRNA - MDWD
31%
Poorly correlated
+0.29%
AKBA - MDWD
29%
Poorly correlated
-7.29%
SCPH - MDWD
28%
Poorly correlated
-4.11%
OABI - MDWD
28%
Poorly correlated
-0.94%
XOMA - MDWD
28%
Poorly correlated
N/A
More

SCPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCPH has been loosely correlated with AUTL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SCPH jumps, then AUTL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCPH
1D Price
Change %
SCPH100%
-4.11%
AUTL - SCPH
46%
Loosely correlated
-4.55%
BEAM - SCPH
45%
Loosely correlated
+3.68%
AURA - SCPH
43%
Loosely correlated
+2.41%
YMAB - SCPH
43%
Loosely correlated
-1.45%
CRSP - SCPH
41%
Loosely correlated
-1.97%
More